Image Novo Nordisk offices in Fremont, California./Shutterstock Diabetes Drug’s New Weight Loss Formula Fuels Cost-Benefit Debate Ozempic’s peppy ads suggest that people who use it might lose weight, but also include a disclaimer: that it “is not a weight loss drug.” Now — as Wegovy — it is. Aug 1, 2021 Coalition Hopes To Amp Up Push For Health Care Transparency Apr 10, 2015 Subscribe to Novo Nordisk
